US EditionPublished • loading... • Updated
Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
NFI's 2025 revenue rose 16% to $3.6 billion with a $13 billion backlog, boosted by higher deliveries and a $114.5 million net battery settlement recovery.
- On March 11, 2026, NFI announced audited 2025 results from Winnipeg, with a webcast scheduled for March 12, 2026 at 8:30 a.m. ET to review results and guidance, including a detailed investor presentation.
- NFI signed a master settlement with XALT Energy and recorded other income of $166 million, recovering about 72% of the prior $229 million provision, positively impacting its results in fiscal 2025.
- NFI delivered 1,233 EUs in Q4 and recorded $125 million in revenue, with Net Earnings of $166.0 million and Adjusted Net Earnings of $59.6 million.
- NFI Group Inc. expects 2026 revenue of $3,900 to $4,200 million and cautions that tariff or trade-policy shifts could materially impact results, with guidance set at $50 to $60 million for capital expenditures.
- NFI sees a five‑year demand near 25,000 EUs, citing 5,051 EUs of orders on an LTM basis and tariff updates, including a 10% import tariff, as near-term headwinds.
Insights by Ground AI
69 Articles
69 Articles
The Billings Gazette+11 Reposted by 11 other sources
Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
SAN FRANCISCO, March 12, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2025.
·Billings, United States
Read Full Article
Coverage Details
Total News Sources69
Leaning Left14Leaning Right3Center21Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 37%
C 55%
Factuality
To view factuality data please Upgrade to Premium
